Reactivation of Chagas-Mazza disease during treatment with infliximab
- PMID: 29364464
- PMCID: PMC5786422
- DOI: 10.1590/abd1806-4841.20177346
Reactivation of Chagas-Mazza disease during treatment with infliximab
Conflict of interest statement
Conflict of Interests: Galimberti RL is a senior researcher at Novartis, Eli Lilly and AbbVie
Figures
References
-
- who.int [Internet] Organización Mundial de la salud. La enfermedad de Chagas (Tripanosomiasis americana). Nota descriptiva Nº 340. 2012. [08 Abr 2017]. Disponible em: http://www.who.int/mediacentre/factsheets/fs340/es/index.html.
-
- Riganti J, Maqueda MG, Piñero MC, Volonteri VI, Galimberti RL. Reactivation of Chagas' disease: cutaneous manifestations in two immunosuppressed patients. Int J Dermatol. 2012;51:829–834. - PubMed
-
- Jordan R, Valledor A. Guías de recomendaciones de prevención de infecciones en pacientes que reciben modificadores de la respuesta biológica. Rev Arg Reumatol. 2014;25:8–26.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical